Endpoints News 生物医药· Max Bayer·· 2026-10-21AI 评分33
ICER 新报告提示:药品上市价格正超出其价值
New ICER report suggests drug launch prices are outpacing their worth
AI 导读
ICER 新报告提示,药品上市价格正超出其价值。报告称,2022 至 2025 年药品上市时中位标价上涨 24%,净价涨幅更高。
正文
The median list price of drugs at launch rose 24% from 2022 to 2025, and the net prices of those drugs rose even higher, according …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news